Page 2 - U.S. Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Jan 07, 2026

Explore the U.S. (NYSE and NASDAQ) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

719 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
TECH
Bio-Techne
US$65.05-0.4%-13.5%US$10.2bUS$69.17PE130xE23.2%0.5%
IRWD
Ironwood Pharmaceuticals
US$4.08-5.1%-10.9%US$699.5mUS$4.85PE23.2xE16.6%n/a
GOSS
Gossamer Bio
US$2.41-5.9%129.5%US$592.5mUS$9.50PS12.7xE57.9%n/a
TLRY
Tilray Brands
US$8.99-2.9%-34.4%US$1.1bUS$16.17PS1.3xE123.8%n/a
MLYS
Mineralys Therapeutics
US$35.35-1.0%215.6%US$2.8bUS$50.88PB4.9xE49.1%n/a
PRGO
Perrigo
US$14.59-1.1%-41.8%US$2.0bUS$21.00PB0.5xE28.2%8.0%
KNSA
Kiniksa Pharmaceuticals International
US$42.42-0.6%109.0%US$3.2bUS$54.71PE89.5xE31.6%n/a
TWST
Twist Bioscience
US$36.55-0.9%-19.0%US$2.3bUS$37.88PS5.9xE37.1%n/a
CRSP
CRISPR Therapeutics
US$57.99-0.3%40.4%US$5.5bUS$83.17PS144.2xE58.3%n/a
BIOA
BioAge Labs
US$14.91-3.2%192.9%US$552.5mUS$12.00PS90.3xE-17.8%n/a
TENX
Tenax Therapeutics
US$12.85-3.2%98.3%US$538.4mUS$22.90PB5.4xE30.8%n/a
LENZ
LENZ Therapeutics
US$16.31-3.2%-38.1%US$509.7mUS$52.67PS29.2xE56.3%n/a
EOLS
Evolus
US$5.66-4.2%-44.6%US$383.1mUS$18.50PS1.3xE58.1%n/a
NAGE
Niagen Bioscience
US$6.57-2.8%20.6%US$541.4mUS$15.80PE25.8xE29.7%n/a
GRAL
GRAIL
US$103.59-0.4%486.6%US$4.1bUS$105.00PS28.5xE-3.7%n/a
IKT
Inhibikase Therapeutics
US$1.89-5.5%-39.0%US$273.6mUS$6.60PB3.5xE14.0%n/a
LYEL
Lyell Immunopharma
US$25.05-2.6%92.2%US$546.6mUS$29.67PS12979.5xE-2.1%n/a
VRDN
Viridian Therapeutics
US$30.57-0.5%59.6%US$2.9bUS$41.76PS41.2xE52.3%n/a
AMPH
Amphastar Pharmaceuticals
US$27.33-1.1%-25.4%US$1.3bUS$31.57PE11.3xE4.0%n/a
AUTL
Autolus Therapeutics
US$1.95-2.5%-19.1%US$532.3mUS$9.63PS10.2xE47.3%n/a
DWTX
Dogwood Therapeutics
US$3.56-10.3%49.6%US$118.0mUS$19.00PE-2.6xE29.4%n/a
YDES
YD Bio
US$11.50-1.4%8.5%US$819.9mn/aPS1584.5xn/an/a
VTVT
vTv Therapeutics
US$41.99-1.7%199.7%US$530.0mUS$47.25PS30649.3xE-1.7%n/a
SLS
SELLAS Life Sciences Group
US$4.04-1.5%325.1%US$584.0mUS$6.83PB12.6xE52.5%n/a
Page 2 of 30